Bryophyllum vs. Nifedipine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2006 by Weleda AG.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Weleda AG
ClinicalTrials.gov Identifier:
NCT00391339
First received: October 19, 2006
Last updated: NA
Last verified: October 2006
History: No changes posted
  Purpose

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.


Condition Intervention Phase
Tocolysis
Drug: Bryophyllum p.
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Bryophyllum p. Versus Nifedipine for the Treatment of Premature Contractions

Resource links provided by NLM:


Further study details as provided by Weleda AG:

Estimated Enrollment: 140
Study Start Date: November 2006
Estimated Study Completion Date: October 2008
  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female

Exclusion Criteria:

  • Bishop Score > 5
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00391339

Locations
Switzerland
Department of Obstetrics, University of Zuerich Not yet recruiting
Zuerich, Switzerland, 8091
Principal Investigator: Roland Zimmermann, Prof. Dr. med.         
Principal Investigator: Ursula von Mandach, Prof. Dr. pharm.         
Sponsors and Collaborators
Weleda AG
Investigators
Principal Investigator: Roland Zimmermann, Prof. Dr. med. Department of Obstetrics, University Zuerich
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00391339     History of Changes
Other Study ID Numbers: CI-C-64-Wel-06
Study First Received: October 19, 2006
Last Updated: October 19, 2006
Health Authority: Switzerland: Swissmedic

Keywords provided by Weleda AG:
Bryophyllum p.
Nifedipine
Tocolysis

Additional relevant MeSH terms:
Nifedipine
Tocolytic Agents
Reproductive Control Agents
Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses
Calcium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cardiovascular Agents
Vasodilator Agents

ClinicalTrials.gov processed this record on July 24, 2014